Search research articles
Contact Us
Filters
Showing results (1-10 of 42) with videos related to
Page
of 5
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
August 7, 2021
An Overview of Phase 2 Clinical Trial Designs
Pedro A Torres-Saavedra, Kathryn A Winter
Clinical Science (London, England : 1979)
|
October 27, 2006
Inflammatory biomarkers increase with severity of upper-extremity overuse disorders
Stephen J Carp, Mary F Barbe, Kathryn A Winter, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 22, 2011
A Phase II study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246
Stephen G Swisher, Kathryn A Winter, Ritsuko U Komaki, et al.
Practical Radiation Oncology
|
March 3, 2019
NRG Oncology/RTOG 0438: A Phase 1 Trial of Highly Conformal Radiation Therapy for Liver Metastases
Laura A Dawson, Kathryn A Winter, Alan W Katz, et al.
Journal of Pain and Symptom Management
|
June 3, 2015
The Complementary Nature of Patient-Reported Outcomes and Adverse Event Reporting in Cooperative Group Oncology Clinical Trials: A Pooled Analysis (NCCTG N0591)
Pamela J Atherton, Deborah W Watkins-Bruner, Carolyn Gotay, et al.
Urology
|
December 23, 2008
Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy
Donald S Kaufman, Kathryn A Winter, William U Shipley, et al.
Annals of Surgical Oncology
|
April 19, 2011
Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial
William F Regine, Kathryn A Winter, Ross Abrams, et al.
JAMA
|
April 24, 2008
Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial
Jaffer A Ajani, Kathryn A Winter, Leonard L Gunderson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 8, 2003
RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy
Michael P Hagan, Kathryn A Winter, Donald S Kaufman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 14, 2009
US intergroup anal carcinoma trial: tumor diameter predicts for colostomy
Jaffer A Ajani, Kathryn A Winter, Leonard L Gunderson, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 42) with videos related to
Sort By:
Page
of 5
International Journal of Radiation Oncology, Biology, Physics
|
August 7, 2021
An Overview of Phase 2 Clinical Trial Designs
Pedro A Torres-Saavedra, Kathryn A Winter
Clinical Science (London, England : 1979)
|
October 27, 2006
Inflammatory biomarkers increase with severity of upper-extremity overuse disorders
Stephen J Carp, Mary F Barbe, Kathryn A Winter, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 22, 2011
A Phase II study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246
Stephen G Swisher, Kathryn A Winter, Ritsuko U Komaki, et al.
Practical Radiation Oncology
|
March 3, 2019
NRG Oncology/RTOG 0438: A Phase 1 Trial of Highly Conformal Radiation Therapy for Liver Metastases
Laura A Dawson, Kathryn A Winter, Alan W Katz, et al.
Journal of Pain and Symptom Management
|
June 3, 2015
The Complementary Nature of Patient-Reported Outcomes and Adverse Event Reporting in Cooperative Group Oncology Clinical Trials: A Pooled Analysis (NCCTG N0591)
Pamela J Atherton, Deborah W Watkins-Bruner, Carolyn Gotay, et al.
Urology
|
December 23, 2008
Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy
Donald S Kaufman, Kathryn A Winter, William U Shipley, et al.
Annals of Surgical Oncology
|
April 19, 2011
Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial
William F Regine, Kathryn A Winter, Ross Abrams, et al.
JAMA
|
April 24, 2008
Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial
Jaffer A Ajani, Kathryn A Winter, Leonard L Gunderson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 8, 2003
RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy
Michael P Hagan, Kathryn A Winter, Donald S Kaufman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 14, 2009
US intergroup anal carcinoma trial: tumor diameter predicts for colostomy
Jaffer A Ajani, Kathryn A Winter, Leonard L Gunderson, et al.
Page
of 5